DUBLIN, Ohio, April 26, 2019 /PRNewswire/ -- To meet the
growing needs of the market, Cardinal Health Specialty Solutions
has strengthened its cell and gene therapy capability with a
coordinated suite of specialty distribution, third-party logistics
(3PL) services, and specialty pharmacy dispensing services. As part
of this offering, Cardinal Health is announcing a collaboration
with PANTHERx Specialty Pharmacy.
PANTHERx Specialty Pharmacy, THE Rare Disease Specialty
Pharmacy®, is the industry's leading, independent national
specialty pharmacy. PANTHERx's mission is to transform lives by
delivering medical breakthroughs, clinical excellence, and access
solutions to patients afflicted with rare and devastating
conditions.
Cardinal Health has been delivering services for cell and gene
therapies over the past few years using a "buy and bill" model, but
identified an opportunity to augment its offering with specialty
pharmacy services for manufacturers who require a different
reimbursement approach.
"Our current work in cell and gene therapy has helped us
recognize that manufacturers want to customize their channel plans
for these high-touch products – and that may include using a
specialty pharmacy. We are excited about our collaboration with
PANTHERx because of their excellent reputation and deep experience
with rare diseases. While we coordinate with many specialty
pharmacies based on our clients' needs, we believe our relationship
with PANTHERx gives us a unique advantage in the market," said
Joe DePinto, President of Cardinal
Health Specialty Solutions.
"PANTHERx's collaboration with Cardinal Health Specialty
Solutions in cell and gene therapy is unique and compelling. This
relationship produces easier, more successful precision medicine
launches, increased speed to therapy, and enhanced outcomes for
patients," said Dr. Gordon J.
Vanscoy, Chairman and Chief Executive Officer of PANTHERx
Specialty Pharmacy. "This alliance with Cardinal Health generates
real synergies as a result of our respective best-in-class
businesses, a mutual desire to disrupt a fragmented distribution
channel, and a shared can-do attitude. I am confident that our
collaboration will generate tangible benefits for patients while
dramatically simplifying the process for our biopharma
partners."
Through its coordinated cell and gene offering, Cardinal Health
provides manufacturers of precision medicines with a single source
for distribution, 3PL services including order-to-cash management
and reimbursement risk coverage through the 3PL title model, and
specialty pharmacy dispensing. The company also supports cell and
gene therapies with logistics and patient access services.
About Cardinal Health
Cardinal Health, Inc.
(NYSE: CAH) is a global, integrated healthcare services and
products company, providing customized solutions for hospitals,
healthcare systems, pharmacies, ambulatory surgery centers,
clinical laboratories and physician offices worldwide. The company
provides clinically proven medical products, pharmaceuticals and
cost-effective solutions that enhance supply chain efficiency from
hospital to home. Cardinal Health connects patients, providers,
payers, pharmacists and manufacturers for integrated care
coordination and better patient management. To help combat
prescription drug abuse, the company and its education partners
created Generation Rx, a national drug education and awareness
program. Backed by nearly 100 years of experience, with
approximately 50,000 employees in nearly 60 countries, Cardinal
Health ranks #14 on the Fortune 500. For more information,
visit cardinalhealth.com, follow @CardinalHealth on
Twitter, Cardinal Health on Facebook and connect on
LinkedIn at linkedin.com/ company/cardinal-health.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cardinal-health-specialty-solutions-strengthens-cell-and-gene-therapy-offering-with-pantherx-specialty-pharmacy-collaboration-300839030.html
SOURCE Cardinal Health